Detalhe da pesquisa
1.
Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function.
Immunity
; 49(5): 958-970.e7, 2018 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446386
2.
Soluble CTLA-4 attenuates T cell activation and modulates anti-tumor immunity.
Mol Ther
; 32(2): 457-468, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38053333
3.
Hiding in Plain Sight: Soluble Immunomodulatory Receptors.
Trends Immunol
; 39(10): 771-774, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30195467
4.
Improved Multiplex Immunohistochemistry for Immune Microenvironment Evaluation of Mouse Formalin-Fixed, Paraffin-Embedded Tissues.
J Immunol
; 202(1): 292-299, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30510069
5.
Shaving Is an Epiphenomenon of Type I and II Anti-CD20-Mediated Phagocytosis, whereas Antigenic Modulation Limits Type I Monoclonal Antibody Efficacy.
J Immunol
; 201(4): 1211-1221, 2018 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29997125
6.
FcγR requirements leading to successful immunotherapy.
Immunol Rev
; 268(1): 104-22, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26497516
7.
Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies.
Blood
; 125(12): 1901-9, 2015 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25631769
8.
Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ Receptors.
J Immunol
; 195(11): 5503-16, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26512139
9.
Rehabilitation or the death penalty: autoimmune B cells in the dock.
Eur J Immunol
; 45(3): 687-91, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25639261
10.
The soluble isoform of CTLA-4 as a regulator of T-cell responses.
Eur J Immunol
; 43(5): 1274-85, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23400950
11.
Differential Regulation of the STING Pathway in Human Papillomavirus-Positive and -Negative Head and Neck Cancers.
Cancer Res Commun
; 4(1): 118-133, 2024 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147007
12.
Neuroblastoma: an ongoing cold front for cancer immunotherapy.
J Immunother Cancer
; 11(11)2023 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37993280
13.
Worked to the bone: antibody-based conditioning as the future of transplant biology.
J Hematol Oncol
; 15(1): 65, 2022 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35590415
14.
FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms.
Cell Rep
; 40(3): 111099, 2022 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35858562
15.
HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy.
J Exp Clin Cancer Res
; 41(1): 131, 2022 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35392965
16.
Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review.
Front Immunol
; 12: 651687, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33777052
17.
Old Dog, New Trick: Type I IFN-Based Treatment for Acute Myeloid Leukemia.
Mol Cancer Res
; 19(5): 753-756, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33500358
18.
STINGing Viral Tumors: What We Know from Head and Neck Cancers.
Cancer Res
; 81(15): 3945-3952, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33903123
19.
Recent Progress in Interferon Therapy for Myeloid Malignancies.
Front Oncol
; 11: 769628, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34778087
20.
Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia.
Nat Commun
; 12(1): 5395, 2021 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34518531